1
|
Kong D, Wu J, Kong X, Huang J, Zhao Y, Yang B, Zhao Q, Gu K. Effect of bolus materials on dose deposition in deep tissues during electron beam radiotherapy. JOURNAL OF RADIATION RESEARCH 2024; 65:215-222. [PMID: 38331401 PMCID: PMC10959426 DOI: 10.1093/jrr/rrae001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/12/2023] [Revised: 11/27/2023] [Indexed: 02/10/2024]
Abstract
Several materials are utilized in the production of bolus, which is essential for superficial tumor radiotherapy. This research aimed to compare the variations in dose deposition in deep tissues during electron beam radiotherapy when employing different bolus materials. Specifically, the study developed general superficial tumor models (S-T models) and postoperative breast cancer models (P-B models). Each model comprised a bolus made of water, polylactic acid (PLA), polystyrene, silica-gel or glycerol. Geant4 was employed to simulate the transportation of electron beams within the studied models, enabling the acquisition of dose distributions along the central axis of the field. A comparison was conducted to assess the dose distributions in deep tissues. In regions where the percentage depth dose (PDD) decreases rapidly, the relative doses (RDs) in the S-T models with silica-gel bolus exhibited the highest values. Subsequently, RDs for PLA, glycerol and polystyrene boluses followed in descending order. Notably, the RDs for glycerol and polystyrene boluses were consistently below 1. Within the P-B models, RDs for all four bolus materials are consistently below 1. Among them, the smallest RDs are observed with the glycerol bolus, followed by silica-gel, PLA and polystyrene bolus in ascending order. As PDDs are ~1-3% or smaller, the differences in RDs diminish rapidly until are only around 10%. For the S-T and P-B models, polystyrene and glycerol are the most suitable bolus materials, respectively. The choice of appropriate bolus materials, tailored to the specific treatment scenario, holds significant importance in safeguarding deep tissues during radiotherapy.
Collapse
Affiliation(s)
- Dong Kong
- Department of Radiation Oncology, Affiliated Hospital of Jiangnan University, No. 1000, Hefeng Road, Wuxi 214122, China
| | - Jia Wu
- Department of Radiation Oncology, Affiliated Hospital of Jiangnan University, No. 1000, Hefeng Road, Wuxi 214122, China
| | - Xudong Kong
- Department of Radiation Oncology, Affiliated Hospital of Jiangnan University, No. 1000, Hefeng Road, Wuxi 214122, China
| | - Jianfeng Huang
- Department of Radiation Oncology, Affiliated Hospital of Jiangnan University, No. 1000, Hefeng Road, Wuxi 214122, China
| | - Yutian Zhao
- Department of Radiation Oncology, Affiliated Hospital of Jiangnan University, No. 1000, Hefeng Road, Wuxi 214122, China
| | - Bo Yang
- Department of Radiation Oncology, Affiliated Hospital of Jiangnan University, No. 1000, Hefeng Road, Wuxi 214122, China
| | - Qing Zhao
- Pharmaceutical Department, Affiliated Hospital of Jiangnan University, No. 1000, Hefeng Road, Wuxi 214122, China
| | - Ke Gu
- Department of Radiation Oncology, Affiliated Hospital of Jiangnan University, No. 1000, Hefeng Road, Wuxi 214122, China
| |
Collapse
|
2
|
McDermott PN. Internal lead shielding for clinical electron treatments. J Appl Clin Med Phys 2024; 25:e14196. [PMID: 37922411 DOI: 10.1002/acm2.14196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2023] [Revised: 09/27/2023] [Accepted: 10/18/2023] [Indexed: 11/05/2023] Open
Abstract
Electron beams are often used to treat superficial lesions of the lip, cheek, nose, and ear. Lead is frequently used to block distal structures. It is customary to place an internal bolus of low atomic number in between the tissue and the lead to reduce electron backscatter from the lead. Space for the lead and the internal bolus is quite limited. A previous method for estimating the thickness of the lead plus internal bolus is not self-consistent and leads to a larger than necessary thickness. A new method is described here to provide a quick, accurate, and self-consistent estimate of the minimum necessary thickness of the internal bolus and the lead for incident electron beam energies of 4, 6, 8, 9, and 10 MeV as a function of the thickness of the overlying tissue. This method limits the dose enhancement at the tissue/bolus interface due to the underlying lead to 10%. Measurements made with gafchromic film validate this methodology.
Collapse
Affiliation(s)
- Patrick N McDermott
- Beaumont Health, William Beaumont University Hospital, Royal Oak, Michigan, USA
| |
Collapse
|
3
|
Selvaraj J, Rhall G, Ibrahim M, Mahmood T, Freeman N, Gromek Z, Buchanan G, Syed F, Elsaleh H, Quah BJC. Custom-designed Small Animal focal iRradiation Jig (SARJ): design, manufacture and dosimetric evaluation. BJR Open 2020; 2:20190045. [PMID: 33178966 PMCID: PMC7594899 DOI: 10.1259/bjro.20190045] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2019] [Revised: 01/02/2020] [Accepted: 02/16/2020] [Indexed: 12/15/2022] Open
Abstract
OBJECTIVE Preclinical animal models allow testing and refinement of novel therapeutic strategies. The most common preclinical animal irradiators are fixed source cabinet irradiators, which are vastly inferior to clinical linear accelerators capable of delivering highly conformal and precise treatments. The purpose of this study was to design, manufacture and test an irradiation jig (small animal focal irradiation jig, SARJ) that would enable focal irradiation of subcutaneous tumours in a standard fixed source cabinet irradiator. METHODS AND MATERIALS A lead shielded SARJ was designed to rotate animal holders about the longitudinal axis and slide vertically from the base plate. Radiation dosimetry was undertaken using the built-in ion chamber and GAFChromic RTQA2 and EBT-XD films. Treatment effectiveness was determined by irradiating mice with subcutaneous melanoma lesions using a dose of 36 Gy in three fractions (12 Gy x 3) over three consecutive days. RESULTS The SARJ was tested for X-ray shielding effectiveness, verification of dose rate, total dose delivered to tumour and dose uniformity. Accurate and uniform delivery of X-ray dose was achieved. X-ray doses were limited to the tumour site when animal holders were rotated around their longitudinal axis to 15o and 195o, allowing sequential dose delivery using parallel-opposed tangential beams. Irradiation of subcutaneous melanoma tumour established on the flanks of mice showed regression. CONCLUSION SARJ enabled delivery of tangential parallel-opposed radiation beams to subcutaneous tumours in up to five mice simultaneously. SARJ allowed high throughput testing of clinically relevant dose delivery using a standard cabinet-style fixed source irradiator. ADVANCES IN KNOWLEDGE A custom designed jig has been manufactured to fit into conventional cabinet irradiators and is dosimetrically validated to deliver clinically relevant dose distributions to subcutaneous tumours in mice for preclinical studies.
Collapse
Affiliation(s)
| | - Graham Rhall
- The John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia
| | - Mounir Ibrahim
- Medical Physics and Radiation Engineering, Canberra Health Services, Canberra, ACT, Australia
| | - Talat Mahmood
- Medical Physics and Radiation Engineering, Canberra Health Services, Canberra, ACT, Australia
| | - Nigel Freeman
- Medical Physics and Radiation Engineering, Canberra Health Services, Canberra, ACT, Australia
| | - Zennon Gromek
- Medical Physics and Radiation Engineering, Canberra Health Services, Canberra, ACT, Australia
| | | | | | | | | |
Collapse
|
4
|
Soh RCX, Tay GH, Lew WS, Lee JCL. A depth dose study between AAA and AXB algorithm against Monte Carlo simulation using AIP CT of a 4D dataset from a moving phantom. Rep Pract Oncol Radiother 2018; 23:413-424. [PMID: 30197577 DOI: 10.1016/j.rpor.2018.08.003] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2017] [Revised: 05/15/2018] [Accepted: 08/09/2018] [Indexed: 10/28/2022] Open
Abstract
Aim To identifying depth dose differences between the two versions of the algorithms using AIP CT of a 4D dataset. Background Motion due to respiration may challenge dose prediction of dose calculation algorithms during treatment planning. Materials and methods The two versions of depth dose calculation algorithms, namely, Anisotropic Analytical Algorithm (AAA) version 10.0 (AAAv10.0), AAA version 13.6 (AAAv13.6) and Acuros XB dose calculation (AXB) algorithm version 10.0 (AXBv10.0), AXB version 13.6 (AXBv13.6), were compared against a full MC simulated 6X photon beam using QUASAR respiratory motion phantom with a moving chest wall. To simulate the moving chest wall, a 4 cm thick wax mould was attached to the lung insert of the phantom. Depth doses along the central axis were compared in the anterior and lateral beam direction for field sizes 2 × 2 cm2, 4 × 4 cm2 and 10 × 10 cm2. Results For the lateral beam direction, the moving chest wall highlighted differences of up to 105% for AAAv10.0 and 40% for AXBv10.0 from MC calculations in the surface and buildup doses. AAAv13.6 and AXBv13.6 agrees with MC predictions to within 10% at similar depth. For anterior beam doses, dose differences predicted for both versions of AAA and AXB algorithm were within 7% and results were consistent with static heterogeneous studies. Conclusions The presence of the moving chest wall was capable of identifying depth dose differences between the two versions of the algorithms. These differences could not be identified in the static chest wall as shown in the anterior beam depth dose calculations.
Collapse
Affiliation(s)
- Roger Cai Xiang Soh
- Department of Radiation Oncology, National University Cancer Institute, Singapore.,Division of Physics and Applied Physics, Nanyang Technological University, Singapore
| | - Guan Heng Tay
- Division of Radiation Oncology, National Cancer Centre, Singapore
| | - Wen Siang Lew
- Division of Physics and Applied Physics, Nanyang Technological University, Singapore
| | - James Cheow Lei Lee
- Division of Physics and Applied Physics, Nanyang Technological University, Singapore.,Division of Radiation Oncology, National Cancer Centre, Singapore
| |
Collapse
|
5
|
Pan Y, Yang R, Li J, Zhang X, Liu L, Wang J. Film-based dose validation of Monte Carlo algorithm for Cyberknife system with a CIRS thorax phantom. J Appl Clin Med Phys 2018; 19:142-148. [PMID: 29603564 PMCID: PMC5978558 DOI: 10.1002/acm2.12314] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2017] [Revised: 01/01/2018] [Accepted: 02/06/2018] [Indexed: 11/10/2022] Open
Abstract
Monte Carlo (MC) simulation, as the most accurate dose calculation algorithm, is available in the MultiPlan treatment planning system for Cyberknife. The main purpose of this work was to perform experiments to thoroughly investigate the accuracy of the MC dose calculation algorithm. Besides the basic MC beam commissioning, two test scenarios were designed. First, single beam tests were performed with a solid water phantom to verify the MC source model in simple geometry. Then, a lung treatment plan on a CIRS thorax phantom was created to mimic the clinical patient treatment. The plan was optimized and calculated using ray tracing (RT) algorithm and then recalculated using MC algorithm. Measurements were performed in both a homogeneous phantom and a heterogeneous phantom (CIRS). Ion‐chamber and radiochromic film were used to obtain absolute point dose and dose distributions. Ion‐chamber results showed that the differences between measured and MC calculated dose were within 3% for all tests. On the film measurements, MC calculation results showed good agreements with the measured dose for all single beam tests. As for the lung case, the gamma passing rate between measured and MC calculated dose was 98.31% and 97.28% for homogeneous and heterogeneous situation, respectively, using 3%/2 mm criteria. However, RT algorithm failed with the passing rate of 79.25% (3%/2 mm) for heterogeneous situation. These results demonstrated that MC dose calculation algorithm in the Multiplan system is accurate enough for patient dose calculation. It is strongly recommended to use MC algorithm in heterogeneous media.
Collapse
Affiliation(s)
- Yuxi Pan
- Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
| | - Ruijie Yang
- Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
| | - Jun Li
- Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
| | - Xile Zhang
- Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
| | - Lu Liu
- Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
| | - Junjie Wang
- Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
| |
Collapse
|
6
|
Monte Carlo study of radiation dose enhancement by gadolinium in megavoltage and high dose rate radiotherapy. PLoS One 2014; 9:e109389. [PMID: 25275550 PMCID: PMC4183586 DOI: 10.1371/journal.pone.0109389] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2014] [Accepted: 09/01/2014] [Indexed: 12/31/2022] Open
Abstract
MRI is often used in tumor localization for radiotherapy treatment planning, with gadolinium (Gd)-containing materials often introduced as a contrast agent. Motexafin gadolinium is a novel radiosensitizer currently being studied in clinical trials. The nanoparticle technologies can target tumors with high concentration of high-Z materials. This Monte Carlo study is the first detailed quantitative investigation of high-Z material Gd-induced dose enhancement in megavoltage external beam photon therapy. BEAMnrc, a radiotherapy Monte Carlo simulation package, was used to calculate dose enhancement as a function of Gd concentration. Published phase space files for the TrueBeam flattening filter free (FFF) and conventional flattened 6MV photon beams were used. High dose rate (HDR) brachytherapy with Ir-192 source was also investigated as a reference. The energy spectra difference caused a dose enhancement difference between the two beams. Since the Ir-192 photons have lower energy yet, the photoelectric effect in the presence of Gd leads to even higher dose enhancement in HDR. At depth of 1.8 cm, the percent mean dose enhancement for the FFF beam was 0.38±0.12, 1.39±0.21, 2.51±0.34, 3.59±0.26, and 4.59±0.34 for Gd concentrations of 1, 5, 10, 15, and 20 mg/mL, respectively. The corresponding values for the flattened beam were 0.09±0.14, 0.50±0.28, 1.19±0.29, 1.68±0.39, and 2.34±0.24. For Ir-192 with direct contact, the enhanced were 0.50±0.14, 2.79±0.17, 5.49±0.12, 8.19±0.14, and 10.80±0.13. Gd-containing materials used in MRI as contrast agents can also potentially serve as radiosensitizers in radiotherapy. This study demonstrates that Gd can be used to enhance radiation dose in target volumes not only in HDR brachytherapy, but also in 6 MV FFF external beam radiotherapy, but higher than the currently used clinical concentration (>5 mg/mL) would be needed.
Collapse
|
7
|
Javedan K, Feygelman V, Zhang RR, Moros EG, Correa CR, Trotti A, Li W, Zhang GG. Monte Carlo comparison of superficial dose between flattening filter free and flattened beams. Phys Med 2014; 30:503-8. [PMID: 24662096 DOI: 10.1016/j.ejmp.2014.03.001] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/12/2013] [Revised: 01/27/2014] [Accepted: 03/03/2014] [Indexed: 10/25/2022] Open
Abstract
This study investigates the superficial dose from FFF beams in comparison with the conventional flattened ones using a Monte Carlo (MC) method. Published phase-space files which incorporated real geometry of a TrueBeam accelerator were used for the dose calculation in phantom and clinical cases. The photon fluence on the central axis is 3 times that of a flattened beam for a 6 MV FFF beam and 5 times for a 10 MV beam. The mean energy across the field in air at the phantom surface is 0.92-0.95 MeV for the 6 MV FFF beam and 1.18-1.30 MeV for the corresponding flattened beam. At 10 MV, the values are 1.52-1.72 and 2.15-2.87 MeV for the FFF and flattened beams, respectively. The phantom dose at the depth of 1 mm in the 6 MV FFF beam is 6% ± 2.5% (of the maximum dose) higher compared to the flattened beam for a 25 × 25 cm(2) field and 14.6% ± 1.9% for the 2 × 2 cm(2) field. For the 10 MV beam, the corresponding differences are 3.4% ± 1.5% and 10.7% ± 0.6%. The skin dose difference at selected points on the patient's surface between the plans using FFF and flattened beams in the head-and-neck case was 6.5% ± 2.3% (1SD), and for the breast case it was 6.4% ± 2.3%. The Monte Carlo simulations showed that due to the lower mean energy in the FFF beam, the clinical superficial dose is higher without the flattening filter compared to the flattened beam.
Collapse
Affiliation(s)
- Khosrow Javedan
- Radiation Oncology Department, Moffitt Cancer Center, Tampa, FL, USA
| | | | - Ray R Zhang
- School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA
| | - Eduardo G Moros
- Radiation Oncology Department, Moffitt Cancer Center, Tampa, FL, USA
| | - Candace R Correa
- Radiation Oncology Department, Moffitt Cancer Center, Tampa, FL, USA
| | - Andy Trotti
- Radiation Oncology Department, Moffitt Cancer Center, Tampa, FL, USA
| | - Weiqi Li
- Radiation Oncology Department, Moffitt Cancer Center, Tampa, FL, USA
| | - Geoffrey G Zhang
- Radiation Oncology Department, Moffitt Cancer Center, Tampa, FL, USA.
| |
Collapse
|